A carregar...

Orphan Drugs Offer Larger Health Gains but Less Favorable Cost-effectiveness than Non-orphan Drugs

BACKGROUND: Orphan drugs offer important therapeutic options to patients suffering from rare conditions, but are typically considerably more expensive than non-orphan drugs, leading to questions about their cost-effectiveness. OBJECTIVE: To compare the value of orphan and non-orphan drugs approved b...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Gen Intern Med
Main Authors: Chambers, James D., Silver, Madison C., Berklein, Flora C., Cohen, Joshua T., Neumann, Peter J.
Formato: Artigo
Idioma:Inglês
Publicado em: Springer International Publishing 2020
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7458970/
https://ncbi.nlm.nih.gov/pubmed/32291711
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11606-020-05805-2
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!